These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 28133220)
1. [A Case of HER2-Positive Breast Cancer Treated with Nipple-Sparing Mastectomywith Immediate Reconstruction Using a Tissue Expander after Nab-Paclitaxel Combined with Chemotherapy]. Nonomura A; Aomatsu N; Tei S; Haraoka G; Tsujio G; Yamakoshi Y; Wang E; Nagashima D; Hirakawa T; Iwauchi T; Nishii T; Morimoto J; Nakazawa K; Uchima Y; Takeuchi K Gan To Kagaku Ryoho; 2016 Nov; 43(12):2056-2058. PubMed ID: 28133220 [TBL] [Abstract][Full Text] [Related]
2. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment]. Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029 [TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy. Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504 [TBL] [Abstract][Full Text] [Related]
4. [Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response]. Rai Y; Sagara Y; Sagara Y; Takahama T; Matsuyama Y; Ando M; Sagara Y; Ooi Y; Inoue K; Kurosumi M Gan To Kagaku Ryoho; 2007 Jan; 34(1):65-8. PubMed ID: 17220672 [TBL] [Abstract][Full Text] [Related]
5. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer. Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474 [TBL] [Abstract][Full Text] [Related]
6. [Breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy for breast cancer]. Chen J; Lü Q; Wang X; Li H; Chen Y; Yang X; Zeng H Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):872-5. PubMed ID: 24063181 [TBL] [Abstract][Full Text] [Related]
7. High pathologic complete response in Her2-positive, early-stage breast cancer to a novel nonanthracycline neoadjuvant chemotherapy. Zelnak AB; Nikolinakos P; Srinivasiah J; Jonas W; Pippas A; Liu Y; Li X; Torres M; O'Regan RM; Clin Breast Cancer; 2015 Feb; 15(1):31-6. PubMed ID: 25065563 [TBL] [Abstract][Full Text] [Related]
8. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer]. Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072 [TBL] [Abstract][Full Text] [Related]
9. [A Case of Luminal-HER2 Advanced Breast Cancer with Liver Metastasis Showed Pathological Complete Response to the Therapy with Pertuzumab plus Trastuzumab plus Docetaxel]. Hamaoka A; Matsuda T; Konishi E; Taguchi T Gan To Kagaku Ryoho; 2016 Sep; 43(9):1097-100. PubMed ID: 27628551 [TBL] [Abstract][Full Text] [Related]
10. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840 [TBL] [Abstract][Full Text] [Related]
11. [A case of effective trastuzumab plus gemcitabine therapy for human epidermal growth factor receptor 2-positive breast cancer]. Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Jinno H; Kitagawa Y Gan To Kagaku Ryoho; 2013 Nov; 40(12):2396-8. PubMed ID: 24394124 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer. Yardley DA; Raefsky E; Castillo R; Lahiry A; Locicero R; Thompson D; Shastry M; Burris HA; Hainsworth JD Clin Breast Cancer; 2011 Oct; 11(5):297-305. PubMed ID: 21729666 [TBL] [Abstract][Full Text] [Related]
13. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report]. Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023 [TBL] [Abstract][Full Text] [Related]
14. [A Case of Locally-Advanced Breast Cancer with Liver Metastasis, Treated with Mastectomy of the Primary Tumor after Chemotherapy]. Kanada Y; Matsuzaki H; Kobayashi H; Suzuki K; Sawada H; Senba Y; Yoshioka T; Note H; Sato Y; Miyazaki A; Natsume T; Tanaka H; Maruyama T Gan To Kagaku Ryoho; 2015 Nov; 42(12):1509-11. PubMed ID: 26805079 [TBL] [Abstract][Full Text] [Related]
15. Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer. Chen HR; Wu YT; Yu QB; Yang YY; Wei YX; Li HY; Wu KN; Kong LQ World J Surg Oncol; 2017 Oct; 15(1):189. PubMed ID: 29052527 [TBL] [Abstract][Full Text] [Related]
16. [A complete response following treatment with Paclitaxel and bevacizumab for metastatic breast cancer]. Tsubota Y; Sueoka N; Yamamoto D Gan To Kagaku Ryoho; 2014 Nov; 41(12):1954-6. PubMed ID: 25731387 [TBL] [Abstract][Full Text] [Related]
17. [A Case of Locally Advanced Breast Cancer Treated with Modified Radical Mastectomy with Immediate Reconstruction Using a Tissue Expander after Endocrine Therapy]. Aomatsu N; Tei S; Haraoka G; Hosoi K; Fujii N; Tsujio G; Hiramatsu S; Wang E; Iwauchi T; Morimoto J; Nishii T; Kosaka K; Uchima Y; Takeuchi K Gan To Kagaku Ryoho; 2015 Nov; 42(12):1812-4. PubMed ID: 26805181 [TBL] [Abstract][Full Text] [Related]
18. A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment. Shigematsu H; Nakamura Y; Tanaka K; Shiotani S; Koga C; Kawaguchi H; Nishimura S; Taguchi K; Nishiyama K; Ohno S Int J Clin Oncol; 2010 Dec; 15(6):615-20. PubMed ID: 20473628 [TBL] [Abstract][Full Text] [Related]
19. ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy. Li JW; Mo M; Yu KD; Chen CM; Hu Z; Hou YF; Di GH; Wu J; Shen ZZ; Shao ZM; Liu GY PLoS One; 2014; 9(12):e114646. PubMed ID: 25504233 [TBL] [Abstract][Full Text] [Related]
20. [A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock]. Ikeda M; Sonoo H; Oota Y; Fujii S; Shimo T; Miyake A; Seki M; Nomura T; Yamamoto Y; Shiiki S; Nakashima K; Tanaka K; Kurebayashi J Gan To Kagaku Ryoho; 2010 Dec; 37(13):2917-20. PubMed ID: 21160270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]